At a glance
ClinicalIndex Comparison RecordN/ACompleted· 45 enrolled
Drug / intervention
OsseoSpeed™ TXdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open, Prospective, Multi-center Study to Evaluate OsseoSpeed™ TX Single Implant 3 mm Diameter in the Anterior Maxilla. A 3-years Follow-up Study.
In Brief
A clinical study evaluating OsseoSpeed™ TX for Partially Edentulous Jaw. Completed, enrolled 45 participants across 3 sites.
Detailed Summary
The purpose of this study is to investigate the clinical efficacy of OsseoSpeed™ TX 3mm diameter implant in a Chinese population by evaluation of marginal bone level alteration, implant stability and implant survival in the posterior maxilla up to 3 years after loading. Hypothesis: Early loading of the 3 mm implant is a safe and predictable procedure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPartially Edentulous Jaw
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2011
First PostedJul 2011
Primary CompletionAug 2014
Study CompletionAug 2016
TodayJul 2026
First PostedJul 8, 2011
Enrollment StartJun 1, 2011
Primary CompletionAug 1, 2014
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 15.0 years ago
Interventions
OsseoSpeed™ TXdevice
OsseoSpeed™ TX narrow implants (diameter 3 mm) of lengths 11-15 mm